Author

D. Eisenberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:structural biology· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

D. Boyer· 2 shared M. R. Sawaya· 2 shared R. Abskharon· 2 shared A. H. A. Parret· 1 shared A. J. Samelson· 1 shared A. T. Tuukkanen· 1 shared C. Parra Bravo· 1 shared C. T. Chaton· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

D. Boyer

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis

A. J. Samelson, N. Ariqat, J. McKetney, G. Rohanitazangi, C. Parra Bravo, R. Bose, K. J. Travaglini, V. L. Lam, D. Goodness, G. Dixon, E. Marzette, J. Jin, R. Tian, E. Tse, R. Abskharon, , M. Kampmann

The paper uses CRISPR screens in iPSC-derived neurons to identify factors controlling tau aggregation, finding new pathways and potential therapeutic targets for tauopathies.

bioRxiv · Jun 16, 2023Cell Biology

Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2

E. Tayeb-Fligelman, X. Cheng, C. Tai, J. T. Bowler, S. Griner, M. R. Sawaya, P. M. Seidler, Y. X. Jiang, J. Lu, G. M. Rosenberg, L. Salwinski, R. Abskharon, C.-T. Zee, K. Hou, Y. Li, , D. Eisenberg

The paper identifies amyloid-forming segments in SARS-CoV-2 Nucleoprotein and designs peptide inhibitors based on their atomic structures to target Covid-19.

bioRxiv · Mar 5, 2021 · PreprintBiochemistry

A structure-based model for the electrostatic interaction of the N-terminus of protein tau with the fibril core of Alzheimer’s Disease filaments

D. Boyer, D. Eisenberg

The paper models the electrostatic interaction between the N-terminus of tau and the fibril core of Alzheimer’s Disease filaments using crystal structures and molecular modeling.

bioRxiv · Nov 30, 2018Biochemistry

Structural variability of EspG chaperones from mycobacterial ESX-1, ESX-3 and ESX-5 type VII secretion systems

A. T. Tuukkanen, D. Freire, S. Chan, M. A. Arbing, R. W. Reed, T. J. Evans, G. Zenkeviciute, J. Kim, S. Kahng, M. R. Sawaya, C. T. Chaton, M. Wilmanns, D. Eisenberg, A. H. A. Parret, K. V. Korotkov

The paper reports crystal and SAXS structures of EspG chaperones from mycobacterial ESX systems, revealing structural variability and potential substrate binding modes.

bioRxiv · Oct 13, 2018Biochemistry